Búsqueda Imágenes Maps Play YouTube Noticias Gmail Drive Más »
Iniciar sesión
Usuarios de lectores de pantalla: deben hacer clic en este enlace para utilizar el modo de accesibilidad. Este modo tiene las mismas funciones esenciales pero funciona mejor con el lector.

Patentes

  1. Búsqueda avanzada de patentes
Número de publicaciónUS20030028072 A1
Tipo de publicaciónSolicitud
Número de solicitudUS 10/245,992
Fecha de publicación6 Feb 2003
Fecha de presentación17 Sep 2002
Fecha de prioridad31 Ago 2000
También publicado comoUS6591138, US7601116, US9033861, US20060205993, US20090318747, US20150217127
Número de publicación10245992, 245992, US 2003/0028072 A1, US 2003/028072 A1, US 20030028072 A1, US 20030028072A1, US 2003028072 A1, US 2003028072A1, US-A1-20030028072, US-A1-2003028072, US2003/0028072A1, US2003/028072A1, US20030028072 A1, US20030028072A1, US2003028072 A1, US2003028072A1
InventoresDavid Fischell, Adrian Upton
Cesionario originalNeuropace, Inc.
Exportar citaBiBTeX, EndNote, RefMan
Enlaces externos: USPTO, Cesión de USPTO, Espacenet
Low frequency magnetic neurostimulator for the treatment of neurological disorders
US 20030028072 A1
Resumen
A system for treating neurological conditions by low-frequency time varying electrical stimulation includes an electrical device for applying such low-frequency energy, in a range below approximately 10 Hz, to the patient's brain tissue. An implantable embodiment applies direct electrical stimulation to electrodes implanted in or on the patient's brain, while a non-invasive embodiment causes a magnetic field to induce electrical currents in the patient's brain.
Imágenes(6)
Previous page
Next page
Reclamaciones(8)
What is claimed is:
1. A magnetic depolarizer system for the treatment of a neurological disorder, the system comprising:
a readily portable magnetic depolarizer adapted for placement at a specific location onto the head of a patient who is subjected to neurological events, the magnetic depolarizer having a least one electromagnetic coil that is capable of providing a time varying magnetic field pulsed on and off at a rate between approximately 0.1 and 10 Hz, the magnetic field having a peak intensity at some portion of the patient's brain of at least 0.1 Tesla;
electrical circuitry connected to the magnetic depolarizer for providing an electrical current through the at least one electromagnetic coil, the electrical circuitry including at least one operating parameter that is preset by a physician; and,
a positioner for placing the magnetic depolarizer system onto a specific region of the head of the patient.
2. The magnetic depolarizer system of claim 1, wherein the operating parameter comprises a frequency of application for the time varying magnetic field.
3. The system of claim 1 wherein the magnetic depolarizer utilizes two coils, in a race-track, figure-eight configuration.
4. The system of claim 1 wherein the electronic circuitry is adapted to deliver at least one time varying magnetic pulse.
5. A magnetic depolarizer system for the treatment of a neurological disorder, the system comprising:
a readily portable magnetic depolarizer adapted for placement at a specific location onto the head of a patient who is subjected to neurological events, the magnetic depolarizer having a least one electromagnetic coil that is capable of providing a time varying magnetic field having a stimulation frequency between approximately 0.1 and 10 Hz, the magnetic field having a peak intensity at some portion of the patient's brain of at least 0.1 Tesla;
electrical circuitry connected to the magnetic depolarizer for providing an electrical current through the at least one electromagnetic coil, the electrical circuitry including at least one operating parameter that is preset by a physician; and,
a positioner for placing the magnetic depolarizer system onto a specific region of the head of the patient.
6. The magnetic depolarizer system of claim 5, wherein the time varying magnetic field has a carrier frequency of at least 100 Hz.
7. The magnetic depolarizer system of claim 5, wherein the time varying magnetic field has a substantially sinusoidal waveform.
8. A method for treating a neurological disorder in a patient with a readily portable magnetic depolarizer, the method comprising the steps of:
detecting a neurological event related to the neurological disorder;
activating the magnetic depolarizer; and
generating a time-varying magnetic field having a peak intensity at some portion of the patient's cerebral cortex of at least approximately 0.1 Tesla and a frequency of between approximately 0.1 Hz and 10 Hz.
Descripción
    CROSS-REFERENCE TO RELATED APPLICATION
  • [0001]
    This is a division of U.S. Application Ser. No. 09/652,964, filed on Aug. 31, 2000.
  • FIELD OF THE INVENTION
  • [0002]
    This invention is in the field of devices for the treatment of neurological disorders in human subjects, particularly those disorders that originate in the brain.
  • BACKGROUND OF THE INVENTION
  • [0003]
    The current state of the art in treating neurological disorders such as epilepsy or Parkinson's disease involves either drugs, destructive nigral lesions or the open-loop electrical stimulation of neurological tissue. Drug therapy has been shown to have significant short and long-term side effects and is often ineffective. In U.S. Pat. No. 3,850,161, Liss describes a continuous closed-loop feedback system which will always feedback part of the brain EEG signal to separate electrodes so that if a large EEG signal occurs it will be fed back in an attempt to cancel out the original signal. This system does not take advantage of recently developed digital signal processing and microcomputer technology by which feedback signals can be activated only when a neurological event occurs, nor does it provide a practical way to recognize and intervene during early stages in the evolution of a neurological event. In addition, the Liss device is not programmable and it does not provide any capability to record EEG signals. Examples of a “neurological event” are the occurrence of an epileptic seizure, a tremor or the occurrence of a migraine aura or migraine headache. A “neurological event” is defined herein as either the precursor of an event such as an epileptic seizure, or the event itself. This concept of detecting an electrical precursor that is a first type of neurological event that occurs some time before the “real” event (i.e. anomalous brain electrical activity or a particular pattern of neural activity associated with clinical symptoms) is an important aspect of the present invention. It has been shown that both epileptic seizures and Parkinson's tremors have precursors that occur before and can be used to predict the onset of the clinical symptom. It is also very likely that other neurological events such as migraine headaches and depression would have anomalous electrical activity predictive of the onset of clinical symptoms. Methods for prediction of epileptic seizures have been published by Elger and Lehnertz (in Elger, C. E., and Lehnertz, K., “Seizure prediction by non-linear time series analysis of brain electrical activity,” Eur. J. Neurosci. February 1998; 10(2):786-9, and Osorio, Frei and Wilkinson (in Osorio, I., et al., “Real-time automated detection and quantitative analysis of seizures and short-term prediction of clinical onset,” Epilepsia June 1998 ; 39(6):615-27.
  • [0004]
    Maurer and Sorenson in U.S. Pat. No. 4,019,518 describe a combined internal/external system for electrical stimulation of the body with biphasic pulses but do not describe any means of detecting neurological events. Fischell in U.S. Pat. No. 4,373,527 describes a programmable medication infusion system but does not anticipate its use in response to a detected neurological event.
  • [0005]
    More recently, a device has been approved for human use to stimulate the vagus nerve in a continuous fashion with the objective of decreasing the rate of epileptic seizures. Clinical reports on such devices indicate only a modest degree of success in that only 50% of the patients experience a greater than 20% reduction in the rate of epileptic seizures. Another device that has been recently introduced into clinical practice utilizes intermittent or continuous stimulation of the thalamus for the treatment of involuntary motion disorders such as Parkinson's syndrome. Neither of these two open-loop devices described above is highly effective for the treatment of a neurological disorder such as epilepsy, and neither anticipates the use of decision making in order to optimize a response to terminate the precursor of a neurological event or the neurological event itself; nor does either device allow for the recording of EEG signals. In addition, both known devices use stimulation frequencies above 10 Hz, which for the reasons set forth in detail below, are not optimal.
  • [0006]
    Fischell et al in U.S. Pat. No. 6,016,449, which is incorporated herein by reference, teaches a fully implantable neurostimulator capable of responsive treatment of neurological disorders. However, Fischell does not discuss in detail the advantageous use of low frequency stimulation as a means of inhibiting epileptiform activity.
  • [0007]
    It is well known that slow wave potentials in the brain are often inhibitory in nature yet all known stimulation attempts to treat epilepsy in humans have used relatively high frequency stimulation, in most cases greater than 20 Hz. These higher frequencies, while effective for a brain mapping type procedure, have significant potential to induce epileptogenic activity. In fact, Hallett in “Transcranial magnetic stimulation and the human brain,” Nature, Vol. 406, 13 July 2000, states that while “rapid repetitive transcranial magnetic stimulation (rTMS), at frequencies of 5 Hz and higher, will transiently enhance motor excitability . . . slow rTMS, at 1 Hz will transiently depress excitability.”
  • SUMMARY OF THE INVENTION
  • [0008]
    There is good evidence that slow wave activity is inhibitory in the central nervous system of man (Staton, R. D. et al., “The electroencephalographic pattern during electroconvulsive therapy: V. Observations on the origins of phase III delta energy and the mechanism of action of ECT,” Clin. Electroencephalogr. October 1988; 19(4):176-198 and animals (Buzsaki, G. et al., “Depth profiles of hippocampal rhythmic slow activity (‘theta rhythm’) depend on behaviour,” Electroencephalogr. Clin. Neurophysiol. July 1985; 61(1):77-88) including such stimulation applied to the hippocampus (Leung, L. S. et al., “Theta-frequency resonance in hippocampal CA1 neurons in vitro demonstrated by sinusoidal current injection,” J. Neurophysiol. March 1998; 79(3):1592-6). These slow waves may be at theta frequencies (4 to 7 Hz—Buzsaki et al. 1985), delta frequencies (1 to 3 Hz—Staton et al. 1988), or even at less then 1 Hz (Contreras, D. et al., “Cellular basis of EEG slow rhythms: a study of dynamic corticothalamic relationships,” J. Neurosci. January 1995; 15(1 Pt 2):604-22). Paatta et al. (in “Control of chronic experimental focal epilepsy by feedback caudatum stimulation,” Epilepsia August 1983; 24(4):444-54) describe successful ictal spike depression by 5 Hz stimulation of the caudate nucleus (CN) in cat brains. The article also states that stimulation of the thalamus, mesencephalic reticular formation or hypothalamus was not effective. Finally, Hallett (in “Transcranial magnetic stimulation and the human brain,” Nature 2000; 406 (July 13): 147-150) discusses the inhibitory effects of low frequency pulsing from a transcranial magnetic stimulator.
  • [0009]
    The present invention includes transcranial stimulation, or direct brain stimulation from multiple electrodes, in either an open or closed-loop system for the treatment of certain neurological disorders such as epilepsy, migraine headaches and Parkinson's disease. A purpose of the present invention is to overcome the shortcomings of all known devices for the treatment of such disorders. Specifically, the present invention utilizes slow wave potentials (low frequency stimulation in a range of approximately 1 to 10 Hz) to prevent or abort a neurological event.
  • [0010]
    One embodiment of the present invention envisions a multiplicity of brain electrodes placed either within the brain, on the surface of the brain itself, or on the dura mater that surrounds the brain. Some or all of these brain electrodes may be used to directly detect an abnormal neurological event such as an epileptic seizure, or they may be used to detect a pattern of electrical activity that precedes or accompanies an abnormal neurological event. A stimulation signal can also be applied to any one, several, or all elements of such an electrode array. The stimulation signals sent to each electrode may be identical or they may be programmed to differ in amplitude, frequency, waveform, phase and time duration. It is also envisioned that sensing electrodes may be entirely separate from the electrodes used for responsive stimulation.
  • [0011]
    It is also envisioned that appropriate selection (i.e., location) of electrode sites can be used to enhance the reliability for detection and termination of a neurological event. Thus, the present invention envisions enhancement of detection by the use of the spatial domain as it applies to the positioning of detection and treatment electrodes.
  • [0012]
    A specific capability of this system is to provide electrical stimulation to a specific portion of the brain as the means of stopping a neurological event. It is believed that the earliest possible detection of a seizure and treatment of aberrant electrical activity from an epileptic focus has the highest probability of aborting the occurrence of a full seizure. It is envisioned that either through specific placement of treatment electrodes or by adjusting the phase of signals applied to an array of electrodes, stimulation can be directed to the location(s) within the brain that offer the highest probability of stopping the seizure. Detection of an abnormal neurological event would allow detection of specific but apparently normal patterns of electrical activity, which are reliable producers of the abnormal event; stimulation during the appearance of such patterns may prevent the occurrence of the event.
  • [0013]
    A novel aspect of a preferred embodiment of this invention is that the entire implantable portion of this system for treating neurological disorders is implanted under the patient's scalp or intracranially. Such placement will either have the device located between the scalp and the cranium or the within a hole in the cranium. Because of size constraints, the intracranial location is the preferred embodiment.
  • [0014]
    The implantable portion of the system includes: (1) electrodes that lie in close proximity to or actually within the brain, (2) a control module that contains a battery and all the electronics for sensing, recording and controlling brain activity, (3) electrically conducting wires that connect the control module to the electrodes, (4) a buzzer providing an acoustic signal or electrical “tickle” indicating that a neurological event has been detected, and (5) an input-output wire coil (or antenna) used for communication of the implanted system with any and all external equipment. The battery that provides power for the system and an electronics module are both contained within a metal shell that lies, in one embodiment, under the patient's scalp. The metal shell, which contains the electronics module and the battery collectively, forms the control module.
  • [0015]
    All electrodes connect by way of electrically conducting wires to electrical terminals that are formed into the metal shell. The electronics module is electrically joined to the brain electrodes by way of the shell's electrical terminals, which are electrically joined to the wires that connect to the brain electrodes.
  • [0016]
    An important aspect of the preferred embodiment of this device is the fact that the shell containing the electronics module and the battery, i.e. the control module, is to be placed in the cranium of the skull at a place where a significant volume of bone is removed. By placing the entire system within the cranium, (as opposed to having some wires extending into or through the patient's neck to a control module in the chest) the probability of wire breakage due to repeated wire bending is significantly reduced. However, the present invention also envisions the placement in the chest or abdomen of a control module if a large battery or a large volume electronics module dictates such a large size for the control module that it cannot be conveniently placed within the cranium. Such a thoracic or abdominal placement of a control module would typically require wires to be run through the patient's neck.
  • [0017]
    The present invention also envisions the utilization of an intracranial system for the treatment of certain diseases without placing wires through the neck. Specifically, an alternative embodiment of the invention envisions the use of electrodes in or on the brain with an intracranial control module used in conjunction with a remote sensor/actuator device implanted elsewhere in the patient's body. For example, blood pressure could be sensed with a threshold of, for example, 150 mm Hg, and if that pressure is exceeded, a signal transmitted by electrical conduction through the body from the remote sensor/actuator device could be received at the control module, which would initiate brain stimulation in such a way as to reduce the blood pressure. Conversely, if the brain perceives pain and generates a corresponding signal detectable by the intracranial control module, a signal could be sent by electrical conduction through the body to the remote sensor/actuator device, which would provide responsive electrical stimulation to locally stimulate a nerve, thereby reducing the perception of that pain. In still another embodiment, if a precursor of an epileptic seizure is detected, the remote sensor/actuator could be used to electrically stimulate one or both vagus nerves so as to stop the epileptic seizure from occurring. Such a remote device could be located in the trunk of the patient's body. In an embodiment of the invention, a remote sensor/actuator may be used to deliver instantaneous, intravenous, intraperitoneal, subdural or intraventricular (of the brain) therapeutic chemicals, including medication, neurotransmitters and ionic substances, alone or in conjunction with electrical stimulation. Such a remote sensor/actuator is disclosed in the above referenced U.S. Pat. No. 6,016,449 by Fischell et al.
  • [0018]
    It is also envisioned the ideal stimulation to prevent or abort a neurological event has a low frequency (e.g., 1 to 8 Hz) that would resemble slow wave inhibitory potentials and be significantly less likely to induce epileptiform activity. In one embodiment of the invention, the stimulation waveform is substantially sinusoidal and has minimal higher-order harmonics, and hence little energy above the fundamental frequency. In an alternative embodiment, the low frequency stimulation comprises a sequence of short duration biphasic pulses having a repetition rate of less than about ten pulses per second (10 Hz). Such stimulation could be applied to the caudate nucleus or other structures of the brain, including the hippocampus. As patients suffering from Parkinson's have an extremely low incidence of epilepsy and one manifestation of Parkinson's is characterized by a 5 Hz electrical oscillation that begins in the Thalamus, it is conceived that low frequency stimulation of the Thalamus could, in fact, be inhibitory to epileptiform activity. Such stimulation could be responsive to the detection of a precursor to a clinical seizure or the epileptiform activity from the seizure itself. Alternately, periodic slow wave stimulation applied without detection could prevent the brain from generating seizure activity. Although epilepsy is currently believed to be the most applicable use of such slow wave stimulation, it could also be successful for migraines, pain, tremor, Parkinson's, depression or other neurological disorders.
  • [0019]
    It is also envisioned that while the standard treatment would have a constant amplitude for the duration of the low frequency stimulation, it may be advantageous to have the amplitude begin high and decrease over the duration, begin low and increase over the duration, or vary according to any desired treatment plan. The typical duration of low frequency stimulation that would be used to stop a neurological event would be between 100 ms and 10 seconds.
  • [0020]
    Another embodiment of the present invention that would be significantly less invasive involves the use of Transcranial Magnetic Stimulation (TMS) from an external coil TMS stimulator. Such a device could be incorporated into a bicycle type helmet and could be used at the time a pre-event aura is sensed by the patient. Alternately, such an external system could be used in a repetitive or continuous mode for patients with serious disorders who often wear protective helmets. A TMS device could be extremely effective if it is pulsed on and off at frequencies below 10 Hz.
  • [0021]
    Thus it is an object of this invention to provide appropriate slow wave stimulation of the human brain in response to a detected neurological event in order to cause the cessation of that neurological event. The pattern and frequency of stimulation can be modified to provide optimal control of the unwanted neurological event in each patient.
  • [0022]
    Another object of this invention is to use periodic slow wave stimulation of the brain to treat neurological disorders.
  • [0023]
    Another object of this invention is to use continuous slow wave stimulation of the brain to treat neurological disorders.
  • [0024]
    Still another object of this invention is to have a system of electrodes connected by wires to a control module, the entire system being placed under the scalp or intracranially, and being substantially contained within an opening in the cranium.
  • [0025]
    Still another object of this system is to have essentially no flexure of interconnecting wires so as to enhance system reliability.
  • [0026]
    These and other objects and advantages of this invention will become apparent to a person of ordinary skill in this art upon careful reading of the detailed description of this invention including the drawings as presented herein.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0027]
    [0027]FIG. 1 is a top view of a human head showing the configuration of an implantable system for the treatment of neurological disorders, as it would be situated in the human skull.
  • [0028]
    [0028]FIG. 2 is a block diagram of the implanted and external portions of the system.
  • [0029]
    [0029]FIG. 3 is a cross section of an embodiment of the present invention showing a magnetic depolarizer system within a helmet on the head of a patient.
  • [0030]
    [0030]FIG. 4A is a longitudinal cross section of the magnetic depolarizer.
  • [0031]
    [0031]FIG. 4B is a top view of the magnetic depolarizer.
  • [0032]
    [0032]FIG. 5 is a simplified circuit diagram of the main components of a magnetic depolarizer system.
  • DETAILED DESCRIPTION OF THE DRAWINGS
  • [0033]
    [0033]FIG. 1 illustrates the configuration of an implantable system 10 for the treatment of neurological disorders as it would be situated under the scalp of a human head 9, the system including a control module 20, electrodes 15A, 15B, 15C, 15N and 16 with wires 17A, 17B, 17C, 17N and 18 connected through a connector 8 to the control module 20. It is envisioned that the control module 20 is permanently implanted into the top of the patient's skull in a location where the skull is fairly thick. It is also envisioned that the control module 20 could be located in the trunk of the patient's body like a heart pacemaker with the connecting wires being run through the patient's neck, under the patient's skin or otherwise. Each of the electrodes 15A, 15B, 15C, 15N and 16 would be placed under the cranium and above the dura mater (i.e., placed epidurally) or placed deep into the brain. The connecting wires 17A, 17B, 17C, 17N and 18 would be run from the control module 20 underneath the scalp and then be connected to the electrodes placed beneath the patient's cranium. Although FIG. 1 shows only four active electrodes 15A, 15B, 15C, 15N with connecting wires 17A, 17B, 17C, 17N, more than four active electrodes with connecting wires may be used with the present invention. The electrode 16 (having the connecting wire 18) could be considered a common or indifferent electrode.
  • [0034]
    Throughout the detailed description of the present invention, the terminology “the electrodes 15A through 15N” is meant to include all electrodes 15A, 15B, 15C, . . . to 15N, inclusive, where N may be any integer greater than or equal to 1. Similar terminology using the words “through” or “to” for other groups of objects (i.e., wires 17A through 17N) will have a similar inclusive meaning.
  • [0035]
    Throughout FIGS. 1 through 25, inclusive, lines connecting boxes on block diagrams or on software flow charts will each be labeled with an element number. Lines without arrows between boxes or other elements shall indicate a single wire.
  • [0036]
    Lines with arrows connecting boxes or other elements are used to represent any of the following:
  • [0037]
    1. A physical connection, namely a wire or group of wires (data bus) over which analog or digital signals may be sent.
  • [0038]
    2. A data stream sent from one hardware element to another. Data streams include messages, analog or digital signals, commands, EEG information, and software downloads to change system operation and parameters.
  • [0039]
    3. A transfer of information between software modules. Such transfers include software subroutine calls with and without the passing of parameters, and the reading and writing of memory locations.
  • [0040]
    In each case, the descriptive text herein will indicate each specific use of a line with an arrow.
  • [0041]
    [0041]FIG. 2 is a block diagram of the implantable system 10 and the external equipment 11. The wires 17A through 17N from the electrodes 15A through 15N, and the wire 18 from the common electrode 16, are shown connected to both an event detection sub-system 30 and a stimulation sub-system 40. In one embodiment of the invention, it is also envisioned to use the case of the control module 20 of FIG. 1 as the common (or indifferent) electrode 16. The wires 17A through 17N carry EEG signals 21A through 21N from the electrodes 15A through 15N to the event detection sub-system 30. The electrodes 15A through 15N can be energized by the stimulation sub-system 40 via the wires 17A through 17N to electrically stimulate the patient's brain using the stimulation signals 412A through 412N respectively. Although the electrodes 15A through 15N and 16 shown here are connected to both the event detection sub-system 30 and the stimulation sub-system 40, it should be apparent that a separate set of electrodes and associated wires could be used with each sub-system. Furthermore, it is envisioned that any one or more of the electrodes 15A through 15N could be electrically connected (i.e., shorted) to the electrode 16 or to each other. This would be accomplished by appropriate switching circuitry in the stimulation sub-system 40.
  • [0042]
    The event detection sub-system 30 receives the EEG signals 21A through 21N (referenced to a system ground 19 connected to the wire 18 from the common electrode 16) and processes them to identify neurological events such as an epileptic seizure or its precursor. A central processing system 50 with a central processor 51 and memory 55 acts to control and coordinate all functions of the implantable system 10. A first interconnection 52 is used to transmit programming parameters and instructions to the event detection sub-system 30 from the central processing system 50. A second interconnection 53 is used to transmit signals to the central processing system 50 identifying the detection of a neurological event by the event detection sub-system 30. The second interconnection 53 is also used to transmit EEG and other related data for storage in the memory 55.
  • [0043]
    When an event is detected by the event detection sub-system 30 (by processing such as that disclosed and described in U.S. Pat. No. 6,016,449 to Fischell, et al., referenced above), the central processor 51 can command the stimulation sub-system 40 via a third interconnection 54 to transmit electrical signals to any one or more of the electrodes 15A through 15N via the wires 17A through 17N. It is anticipated that, if appropriate, electrical signals 412A to 412N, inclusive, are transmitted to certain locations in or near the brain, thereby aborting the normal progression of an epileptic seizure. It may also be necessary for the stimulation sub-system 40 to temporarily disable the event detection sub-system 30 via a fourth interconnection 29 when stimulation is imminent so that the stimulation signals are not inadvertently interpreted as a neurological event by the event detection sub-system 30.
  • [0044]
    The stimulation sub-system 40 may also be engaged to perform continuous or periodic stimulation to the brain electrodes 15A through 15N, inclusive. In one embodiment of the invention, electrical stimulation from the stimulation sub-system 40 can include any of a wide range of frequencies from approximately 2 Hz to approximately 200 Hz. Details of a signal generator capable of generating waveforms over such a frequency range are well known in the art of electronics design. In connection with the invention, it is, however, highly desirable to use stimulation at frequencies below 10 Hz. In particular, 5 Hz stimulation has been shown to be inhibitory to ictal spikes in cat brains, and it is believed to be similarly effective in human patients. It is also known to be less likely for low frequency stimulation to induce epileptiform activity.
  • [0045]
    In one embodiment of the invention, the low-frequency stimulation applied by an apparatus according to the invention comprises a substantially sinusoidal waveform having little or no energy in higher-frequency harmonics.
  • [0046]
    A power supply 90 provides power to each component of the system 10. Power supplies for comparable implantable devices such as heart pacemakers and heart defibrillators are well known in the art of implantable electronic devices. Such a power supply typically utilizes a primary (non-rechargeable) storage battery with an associated d-c to d-c converter to obtain any voltages required for the implantable system 10. However, it should be understood that in an alternative embodiment of the invention, the power supply could use a rechargeable battery that is charged by means of a coil of wire in the control module 20 that receives energy by magnetic induction from an external coil that is placed outside the patient but in close proximity to the control module 20. The implanted coil of wire could also be located remotely from control module 20 but joined to it by electrical wires. Such technology is well known from the rechargeable cardiac pacemaker. Furthermore, the same pair of coils of wire could be used to provide power to the implanted system 10 when it is desired to read out stored telemetry or reprogram some portion of the implanted system 10.
  • [0047]
    The central processing system 50 is connected to a data communication sub-system 60, thereby allowing data stored in the memory 55 to be retrieved by the patient's physician via a wireless communication link 72. An external data interface 70 can be directly connected to the physician's workstation 80 via a traditional serial data connection 74 (such as an RS-232 interface). Alternately, the serial connection may be made trans-telephonically, via modems 85 and 750 and a phone line 75 from the patient's home to the physician's workstation 80. Software in the computer section of the physician's workstation 80 allows the physician to read out a history of events detected by the implantable system 10, including EEG information before, during and after each event, as well as specific information relating to the detection of the event, such as the time evolving energy spectrum of the patient's EEG. In a preferred embodiment of the invention, the physician's workstation 80 also allows the physician to specify or alter any programmable parameters of the implantable system 10.
  • [0048]
    As shown in FIGS. 1 and 2, a buzzer 95 connected to the central processor 51 via a link 92 can be used to notify the patient that a neurological event has occurred, the implanted system 10 is about to deliver stimulation, or that the implanted system 10 is not functioning properly. In alternative embodiments, the buzzer could provide a mechanical vibration (typically an acoustic signal) or an electrical stimulation “tickle,” either of which could be perceived by the patient. By placing the buzzer 95 near the ear and on the top of, below, or within a burr hole in the cranium, an acoustic signal emitted by the buzzer 95 would be transmitted via bone conduction and detectable by the patient's ear. This sound by itself can be an automatic means for stopping an epileptic seizure.
  • [0049]
    A real time clock 91 is used for timing and synchronizing various portions of the implanted system 10 and also to enable the system to provide the exact date and time corresponding to each neurological event that is detected by the implantable system 10 and recorded in the memory 55. A fifth interconnection 96 is used to send data from the central processor 51 to the real time clock 91 in order to set the correct date and time in the clock 91.
  • [0050]
    The various interconnections between sub-systems (e.g., the illustrated interconnections 29, 52, 53, 54, 56, 57, 92, 93 and 96) may be either analog or digital, single wire or multiple wires (a “data bus”).
  • [0051]
    In an embodiment of the invention, the operation of the system 10 of FIG. 2 for detecting and treating a neurological event such as an epileptic seizure would typically be as follows:
  • [0052]
    1. The event detection sub-system 30 continuously processes the EEG signals 21A through 21N carried by the wires 17A through 17N from the N electrodes 15A through 15N.
  • [0053]
    2. When an event is detected, the event detection sub-system 30 notifies the central processor 51 via the second interconnection 53 that an event has occurred.
  • [0054]
    3. The central processor 51 then triggers the stimulation sub-system 40 via the third interconnection 54 to electrically stimulate the patient's brain with low frequency electrical signals in order to stop the neurological event, using any one, several or all of the electrodes 15A through 15N.
  • [0055]
    4. The stimulation sub-system 40 also sends a signal via the fourth interconnection 29 to the event detection sub-system 30 to disable event detection during stimulation to avoid an undesired input into the event detection sub-system 30.
  • [0056]
    5. The central processor system 50 will store EEG signals and event related data received from the event detection sub-system 30 via the second interconnection 53 over a time from X minutes before the event to Y minutes after the event for later analysis by the patient's physician. The value of X and Y may be set from as little as approximately 0.1 minutes to as long as approximately 30 minutes.
  • [0057]
    6. The central processor 51 may generate a “buzz” to notify the patient that an event has occurred by sending a signal via the link 92 to the buzzer 95.
  • [0058]
    An alternative embodiment of the invention is shown in FIG. 3, which illustrates the head of a patient showing a cross section of a non-invasive transcranial magnetic depolarizer system 100 as it would be contained within a helmet 111 of the type used by bicycle riders. The magnetic depolarizer system 100 consists of a magnetic depolarizer coil assembly 112, a battery 114, electronic circuitry 115, a recharging receptacle 116 and interconnecting wires 117. The magnetic depolarizer system 100 is contained within the helmet 111 by means of an elastic support 113 that passes between a front support 111A and a rear support 111B. The purpose of the elastic support 113 is to keep the magnetic depolarizer coil 112 in comparatively tight contact with the patient's head and at a specific location relative to the patient's cerebral cortex.
  • [0059]
    [0059]FIG. 4A is a longitudinal cross section of the magnetic depolarizer 112 of FIG. 3. The magnetic depolarizer coil assembly 112 consists of a first coil 121 placed into a figure-eight configuration with a second coil 122. The two coils 121 and 122 are electrically connected in series in such a way as to create north magnetic poles 121A and 122A in essentially opposite directions when electric current is flowing through the coils 121 and 122. This orientation of coils 121 and 122 can produce a comparatively strong magnetic field onto the cortex of the brain for a distance of a few centimeters beneath the cranium. If the magnetic field changes rapidly in time, it produces an electric current in the brain that can cause excited neurons to be depolarized. Ideally, slow TMS, at 1 to 5 Hz, will transiently depress excitability. In an embodiment of the invention, the intensity of the magnetic field at the surface of the brain should be between 0.1 and 10 Tesla. It is therefore an object of the present invention to use a device such as shown in FIG. 3 pulsed at a slow rate such as 1 or 2 Hz as an external means for treating a neurological disorder; preferably, this frequency is set and evaluated by the patient's physician. Such a device could be worn all the time for chronic epileptics where periodic slow stimulation would act to keep the focal region in a depressed condition, thus preventing a hyper-excited state associated with an epileptic seizure. For patients exhibiting an aura, the helmet could be put on as needed.
  • [0060]
    It should also be understood that the patient could use one or more elastic bands (without a helmet) to place the magnetic depolarizer coil assembly 112 at an appropriate location onto his or her head.
  • [0061]
    [0061]FIG. 4B is a top view of the magnetic depolarizer coil assembly 112 showing as dotted lines the outline of the coils 121 and 122. In both FIGS. 3A and 3B, it is shown that the coils 121 and 122 could be encapsulated into a plastic housing 125. Furthermore, FIG. 3A shows a magnetic core 123 in the coil 121 and a separate magnetic core 124 in the coil 122. These cores 123 and 124 are not required for the device to perform its intended purpose of generating a depolarizing electric current within the cerebral cortex, but their presence facilitates the generation of a high-intensity magnetic field in the brain at a lower level of electric current in the coils 121 and 122. To be effective at the high frequency of the magnetic pulses that are used to stimulate the cortex, the cores 123 and 124 would typically be formed from powdered iron or equivalent ferromagnetic material that has low eddy current and hysteresis losses.
  • [0062]
    Although FIGS. 4A and 4B show a race-track, figure eight type of design for the magnetic depolarizer coil assembly 112, it should be understood that a simple cylindrical coil (and other shaped coils as well) with or without a ferromagnetic core could be used generate the desired time-varying magnetic field.
  • [0063]
    [0063]FIG. 5 is a simplified electrical diagram of the magnetic depolarizer system 100. The rechargeable battery 114 can be recharged through the receptacle 116 by receiving a plug from a conventional AC adapter (not shown) that connects to a-c line voltage (e.g., 115 volts) and delivers an appropriate d-c voltage to recharge the rechargeable battery 114. When the patient is experiencing an aura of a migraine headache or other symptoms of a neurological disorder, he or she can throw the ON-OFF switch 129 to the ON position. That would cause the d-c to d-c converter 130 to activate and generate a high voltage for rapidly charging the capacitor 126. When the control circuitry 128 senses that the appropriate voltage has been reached, it moves the switch 127 from position A to position B thus discharging the capacitor 126 through the coils 121 and 122 of the magnetic depolarizer 112. As previously described, the coils 121 and 122 could have air cores or they could use magnetically permeable cores 123 and 124. The control circuitry 128 can be used to set the repetition rate for causing magnetic pulses to be delivered. For example, a pulse from the capacitor might last for 70 microseconds and could be repeated at the slow frequency rates between approximately 0.1 and 10 Hz. A frequency of 1 Hz has been shown to be effective in depolarizing brain neurons and may be ideal for some patients. However, other patients might find other repetition rates to be more effective. It is even possible that a single magnetic pulse having a time duration between 10 and 1,000 microseconds could be used to stop an aura, thereby preventing the occurrence of a neurological event.
  • [0064]
    In an embodiment of the invention, the TMS administered through a non-invasive magnetic depolarizer system according to the invention comprises a low-frequency signal (between approximately 0.1 Hz and 10 Hz) modulated, via amplitude modulation or frequency modulation, onto a carrier frequency on the order of 100 Hz. It should be recognized that the carrier frequency given here is considered representative of a beneficial and advantageous carrier signal, and that various other carrier frequencies and modulation schemes are possible. Various waveforms are also possible for both the TMS waveform and the carrier waveform, including the substantially sinusoidal wave described above. Circuits capable of generating such stimulus signals are well known to practitioners skilled in the art of electronic circuit design.
  • [0065]
    Although FIGS. 3 and 5 show a battery operated magnetic depolarizer system 100, the system 100 could be operated by plugging into a receptacle at (typically) 115 or 230 volts a-c. Such a system might or might not use a battery as part of its circuitry.
  • [0066]
    Additional objects and advantages of the present invention will become apparent to those skilled in the art to which this invention relates from the subsequent description of the preferred embodiments and the appended claims, taken in conjunction with the accompanying drawings.
Citas de patentes
Patente citada Fecha de presentación Fecha de publicación Solicitante Título
US5707334 *21 Ago 199513 Ene 1998Young; Robert B.Method of treating amygdala related transitory disorders
US5769778 *7 Jul 199723 Jun 1998Somatics, Inc.Medical magnetic non-convulsive stimulation therapy
US6402678 *31 Jul 200011 Jun 2002Neuralieve, Inc.Means and method for the treatment of migraine headaches
Citada por
Patente citante Fecha de presentación Fecha de publicación Solicitante Título
US69266605 Mar 20049 Ago 2005Neuronetics, Inc.Facilitating treatment via magnetic stimulation
US71532568 Sep 200326 Dic 2006Neuronetics, Inc.Reducing discomfort caused by electrical stimulation
US731344229 Abr 200525 Dic 2007Advanced Neuromodulation Systems, Inc.Method of treating mood disorders and/or anxiety disorders by brain stimulation
US73206644 Mar 200422 Ene 2008Neuronetics, Inc.Reducing discomfort caused by electrical stimulation
US734639518 Jun 200418 Mar 2008Advanced Neuromodulation Systems, Inc.Method of treating depression, mood disorders and anxiety disorders using neuromodulation
US739632617 May 20058 Jul 2008Neuronetics, Inc.Ferrofluidic cooling and acoustical noise reduction in magnetic stimulators
US75208489 Abr 200421 Abr 2009The Board Of Trustees Of The Leland Stanford Junior UniversityRobotic apparatus for targeting and producing deep, focused transcranial magnetic stimulation
US75600584 Ene 200614 Jul 2009Neuronetics, Inc.Magnetic core for medical procedures
US760111524 May 200413 Oct 2009Neuronetics, Inc.Seizure therapy method and apparatus
US761499610 Nov 2009Neuronetics, Inc.Reducing discomfort caused by electrical stimulation
US765145926 Ene 2010Neuronetics, Inc.Method and apparatus for coil positioning for TMS studies
US765343326 Ene 2010Advanced Neuromodulation Systems, Inc.Method of treating depression, mood disorders and anxiety disorders using neuromodulation
US76762639 Mar 2010Neurovista CorporationMinimally invasive system for selecting patient-specific therapy parameters
US76848662 Ago 200423 Mar 2010Advanced Neuromodulation Systems, Inc.Apparatus and methods for applying neural stimulation to a patient
US772977318 Oct 20061 Jun 2010Advanced Neuromodualation Systems, Inc.Neural stimulation and optical monitoring systems and methods
US774732528 Sep 200529 Jun 2010Neurovista CorporationSystems and methods for monitoring a patient's neurological disease state
US775658413 Jul 2010Advanced Neuromodulation Systems, Inc.Methods and apparatus for effectuating a lasting change in a neural-function of a patient
US78243242 Nov 2010Neuronetics, Inc.Magnetic core for medical procedures
US783130515 Oct 20029 Nov 2010Advanced Neuromodulation Systems, Inc.Neural stimulation system and method responsive to collateral neural activity
US785332914 Dic 2010Neurovista CorporationMonitoring efficacy of neural modulation therapy
US785774629 Oct 200428 Dic 2010Nueronetics, Inc.System and method to reduce discomfort using nerve stimulation
US79300352 May 200719 Abr 2011Neurovista CorporationProviding output indicative of subject's disease state
US796390321 Jun 2011Neuronetics, Inc.Magnetic core for medical procedures
US797469623 Jul 20055 Jul 2011Dilorenzo Biomedical, LlcClosed-loop autonomic neuromodulation for optimal control of neurological and metabolic disease
US797645116 Jun 200512 Jul 2011The United States Of America As Represented By The Department Of Health And Human ServicesTranscranial magnetic stimulation system and methods
US803673611 Oct 2011Neuro Vista CorporationImplantable systems and methods for identifying a contra-ictal condition in a subject
US80525918 Nov 2011The Board Of Trustees Of The Leland Stanford Junior UniversityTrajectory-based deep-brain stereotactic transcranial magnetic stimulation
US807354612 Jul 20106 Dic 2011Advanced Neuromodulation Systems, Inc.Methods and apparatus for effectuating a lasting change in a neural-function of a patient
US80880583 Ene 2012Neuronetics, Inc.Articulating arm
US811872225 Oct 200521 Feb 2012Neuronetics, Inc.Reducing discomfort caused by electrical stimulation
US817770215 Abr 200415 May 2012Neuronetics, Inc.Method and apparatus for determining the proximity of a TMS coil to a subject's head
US819026412 Ene 201029 May 2012Advanced Neuromodulation Systems, Inc.Method of treating depression, mood disorders and anxiety disorders using neuromodulation
US81953005 May 20115 Jun 2012Advanced Neuromodulation Systems, Inc.Systems and methods for automatically optimizing stimulus parameters and electrode configurations for neuro-stimulators
US824652929 Sep 201021 Ago 2012Neuronetics, Inc.Magnetic core for medical procedures
US826271411 Sep 2012Advanced Neuromodulation Systems, Inc.Techniques for selecting signal delivery sites and other parameters for treating depression and other neurological disorders, and associated systems and methods
US82659109 Oct 200811 Sep 2012Cervel Neurotech, Inc.Display of modeled magnetic fields
US826785026 Nov 200818 Sep 2012Cervel Neurotech, Inc.Transcranial magnet stimulation of deep brain targets
US829593414 Nov 200623 Oct 2012Neurovista CorporationSystems and methods of reducing artifact in neurological stimulation systems
US831570330 Abr 200920 Nov 2012Advanced Neuromodulation Systems, Inc.Methods for targeting deep brain sites to treat mood and/or anxiety disorders
US832643128 Abr 20064 Dic 2012Medtronic, Inc.Implantable medical device for the concurrent treatment of a plurality of neurological disorders and method therefore
US83430271 Ene 2013Ivivi Health Sciences, LlcMethods and devices for providing electromagnetic treatment in the presence of a metal-containing implant
US84123354 Jun 20122 Abr 2013Advanced Neuromodulation Systems, Inc.Systems and methods for automatically optimizing stimulus parameters and electrode configurations for neuro-stimulators
US84151239 Abr 2013Ivivi Health Sciences, LlcElectromagnetic treatment apparatus and method for angiogenesis modulation of living tissues and cells
US843080520 May 200930 Abr 2013Emkinetics, Inc.Method and apparatus for magnetic induction therapy
US843516620 May 20097 May 2013Emkinetics, Inc.Method and apparatus for magnetic induction therapy
US846787818 Jun 2013Advanced Neuromodulation Systems, Inc.Method of treating depression, mood disorders and anxiety disorders using neuromodulation
US850646827 May 200813 Ago 2013Neuronetics, Inc.Ferrofluidic cooling and acoustical noise reduction in magnetic stimulators
US851790812 Ene 201227 Ago 2013Neuronetics, Inc.Reducing discomfort caused by electrical stimulation
US852375315 Ago 20123 Sep 2013Cervel Neurotech, Inc.Transcranial magnet stimulation of deep brain targets
US85385378 Dic 200817 Sep 2013Advanced Neuromodulations Systems, Inc.Systems and methods for providing targeted neural stimulation therapy to address neurological disorders, including neuropyschiatric and neuropyschological disorders
US853854728 Oct 200817 Sep 2013Forschungszentrum Juelich GmbhApparatus for the stimulation of neural networks
US85431992 Sep 201124 Sep 2013Cyberonics, Inc.Implantable systems and methods for identifying a contra-ictal condition in a subject
US858888428 May 201019 Nov 2013Emkinetics, Inc.Microneedle electrode
US858893311 Ene 201019 Nov 2013Cyberonics, Inc.Medical lead termination sleeve for implantable medical devices
US860863421 Mar 200817 Dic 2013The United States Of America, As Represented By The Secretary, Department Of Health And Human ServicesCoil for magnetic stimulation and methods for using the same
US86577315 Jun 200925 Feb 2014Neuronetics, Inc.Magnetic core for medical procedures
US8690748 *2 Ago 20108 Abr 2014Chi Yung FuApparatus for measurement and treatment of a patient
US87236287 Ene 201013 May 2014Cervel Neurotech, Inc.Shaped coils for transcranial magnetic stimulation
US872524328 Dic 200513 May 2014Cyberonics, Inc.Methods and systems for recommending an appropriate pharmacological treatment to a patient for managing epilepsy and other neurological disorders
US876206522 Jun 200524 Jun 2014Cyberonics, Inc.Closed-loop feedback-driven neuromodulation
US87815975 May 201015 Jul 2014Cyberonics, Inc.Systems for monitoring a patient's neurological disease state
US87866242 Jun 201022 Jul 2014Cyberonics, Inc.Processing for multi-channel signals
US878804420 Ene 200622 Jul 2014Michael Sasha JohnSystems and methods for tissue stimulation in medical treatment
US879514826 Oct 20105 Ago 2014Cervel Neurotech, Inc.Sub-motor-threshold stimulation of deep brain targets using transcranial magnetic stimulation
US884550811 Mar 200930 Sep 2014The Board Of Trustees Of The Leland Stanford Junior UniversityRobotic apparatus for targeting and producing deep, focused transcranial magnetic stimulation
US884939029 Dic 200930 Sep 2014Cyberonics, Inc.Processing for multi-channel signals
US885577523 Oct 20127 Oct 2014Cyberonics, Inc.Systems and methods of reducing artifact in neurological stimulation systems
US886464110 Jul 201321 Oct 2014Neuronetics, Inc.Reducing discomfort caused by electrical stimulation
US886817228 Dic 200521 Oct 2014Cyberonics, Inc.Methods and systems for recommending an appropriate action to a patient for managing epilepsy and other neurological disorders
US895627320 Ago 200817 Feb 2015Cervel Neurotech, Inc.Firing patterns for deep brain transcranial magnetic stimulation
US895627416 Jul 201017 Feb 2015Cervel Neurotech, Inc.Transcranial magnetic stimulation field shaping
US89613855 Abr 201124 Feb 2015Ivivi Health Sciences, LlcDevices and method for treatment of degenerative joint diseases with electromagnetic fields
US900247720 Nov 20137 Abr 2015Emkinetics, Inc.Methods and devices for performing electrical stimulation to treat various conditions
US900510226 Abr 201214 Abr 2015Emkinetics, Inc.Method and apparatus for electrical stimulation therapy
US90372242 Ago 201019 May 2015Chi Yung FuApparatus for treating a patient
US904298817 Nov 200526 May 2015Cyberonics, Inc.Closed-loop vagus nerve stimulation
US904418812 May 20142 Jun 2015Cyberonics, Inc.Methods and systems for managing epilepsy and other neurological disorders
US90952662 Ago 20104 Ago 2015Chi Yung FuMethod for treating a patient
US911380129 Dic 200625 Ago 2015Cyberonics, Inc.Methods and systems for continuous EEG monitoring
US91322777 Abr 201415 Sep 2015Cerval Neurotech, Inc.Shaped coils for transcranial magnetic stimulation
US9166441 *9 Ene 201520 Oct 2015Alfred E. Mann Foundation For Scientific ResearchMicroprocessor controlled class E driver
US918030511 Dic 200810 Nov 2015Yeda Research & Development Co. Ltd. At The Weizmann Institute Of ScienceSystems and methods for controlling electric field pulse parameters using transcranial magnetic stimulation
US925959123 Dic 200816 Feb 2016Cyberonics, Inc.Housing for an implantable medical device
US928959518 Nov 201322 Mar 2016Cyberonics, Inc.Medical lead termination sleeve for implantable medical devices
US9295853 *30 Jun 201429 Mar 2016The Trustees Of Columbia University In The City Of New YorkMethods, apparatus, and systems for magnetic stimulation
US93083865 Jun 200912 Abr 2016Neuronetics, Inc.Magnetic core for medical procedures
US932090029 Dic 200626 Abr 2016Cyberonics, Inc.Methods and systems for determining subject-specific parameters for a neuromodulation therapy
US932091316 Abr 201526 Abr 2016Rio Grande Neurosciences, Inc.Two-part pulsed electromagnetic field applicator for application of therapeutic energy
US20020097125 *4 Jun 200125 Jul 2002Kent DaveyMethod for optimizing transcranial magnetic stimulation cores and magnetic cores produced thereby
US20030074032 *15 Oct 200217 Abr 2003Gliner Bradford EvanNeural stimulation system and method responsive to collateral neural activity
US20030088274 *30 Sep 20028 May 2003Vertis Neuroscience, Inc.Method and apparatus for electrically stimulating cells implanted in the nervous system
US20030130706 *27 Sep 200210 Jul 2003Sheffield W. DouglasMethods and apparatus for effectuating a lasting change in a neural-function of a patient
US20040199041 *8 Sep 20037 Oct 2004Riehl Mark EdwardReducing discomfort caused by electrical stimulation
US20040199042 *5 Dic 20037 Oct 2004Riehl Mark EdwardReducing discomfort caused by electrical stimulation
US20040204625 *4 Mar 200414 Oct 2004Riehl Mark EdwardReducing discomfort caused by electrical stimulation
US20050021103 *20 Nov 200327 Ene 2005Dilorenzo Daniel JohnApparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US20050021104 *5 Abr 200427 Ene 2005Dilorenzo Daniel JohnApparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US20050075679 *7 May 20047 Abr 2005Gliner Bradford E.Methods and apparatuses for treating neurological disorders by electrically stimulating cells implanted in the nervous system
US20050148808 *6 Ene 20047 Jul 2005Allan CameronMethod and apparatus for coil positioning for TMS studies
US20050154426 *7 Mar 200514 Jul 2005Boveja Birinder R.Method and system for providing therapy for neuropsychiatric and neurological disorders utilizing transcranical magnetic stimulation and pulsed electrical vagus nerve(s) stimulation
US20050222626 *25 May 20056 Oct 2005Dilorenzo Daniel JCloosed-loop feedback-driven neuromodulation
US20050234286 *15 Abr 200420 Oct 2005Riehl Mark EMethod and apparatus for determining the proximity of a TMS coil to a subject's head
US20050240242 *12 Jul 200427 Oct 2005Dilorenzo Daniel JClosed-loop feedback-driven neuromodulation
US20050261542 *24 May 200424 Nov 2005Riehl Mark ESeizure therapy method and apparatus
US20060064138 *29 Abr 200523 Mar 2006Francisco VelascoMethod of treating mood disorders and/or anxiety disorders by brain stimulation
US20060094924 *29 Oct 20044 May 2006Riehl Mark ESystem and method to reduce discomfort using nerve stimulation
US20060122454 *25 Oct 20058 Jun 2006Neuronetics, Inc.Reducing discomfort caused by electrical stimulation
US20060161039 *20 Ene 200520 Jul 2006Neuronetics, Inc.Articulating arm
US20060199159 *1 Mar 20057 Sep 2006Neuronetics, Inc.Head phantom for simulating the patient response to magnetic stimulation
US20060212090 *1 Mar 200621 Sep 2006Functional Neuroscience Inc.Method of treating cognitive disorders using neuromodulation
US20060212091 *1 Mar 200621 Sep 2006Functional Neuroscience Inc.Method of treating depression, mood disorders and anxiety disorders using neuromodulation
US20060217780 *11 Oct 200528 Sep 2006Gliner Bradford EMethods for treating essential tremor
US20060264692 *17 May 200523 Nov 2006Neuronetics, Inc.Ferrofluidic cooling and acoustical noise reduction in magnetic stimulators
US20060287566 *16 Jun 200521 Dic 2006Abraham ZangenTranscranial magnetic stimulation system and methods
US20060293720 *22 Jun 200528 Dic 2006Dilorenzo Daniel JClosed-loop feedback-driven neuromodulation
US20070005115 *1 Sep 20064 Ene 2007Lozano Andres MMethod of treating depression, mood disorders and anxiety disorders using neuromodulation
US20070027353 *26 Ago 20051 Feb 2007Neuronetics, Inc.Magnetic core for medical procedures
US20070027354 *4 Ene 20061 Feb 2007Neuronetics, Inc.Magnetic core for medical procedures
US20070027355 *27 Jul 20051 Feb 2007Neuronetics, Inc.Magnetic core for medical procedures
US20070032834 *20 Abr 20068 Feb 2007Northstar Neuroscience, Inc.Systems and methods for automatically optimizing stimulus parameters and electrode configurations for neuro-stimulators
US20070073355 *15 Nov 200629 Mar 2007Bioneuronics CorporationApparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US20070088403 *19 Oct 200519 Abr 2007Allen WylerMethods and systems for establishing parameters for neural stimulation
US20070100398 *18 Oct 20063 May 2007Northstar Neuroscience, Inc.Neural stimulation system and optical monitoring systems and methods
US20070142862 *28 Sep 200521 Jun 2007Dilorenzo Daniel JSystems and methods for monitoring a patient's neurological disease state
US20070149952 *28 Dic 200528 Jun 2007Mike BlandSystems and methods for characterizing a patient's propensity for a neurological event and for communicating with a pharmacological agent dispenser
US20070150024 *28 Dic 200528 Jun 2007Leyde Kent WMethods and systems for recommending an appropriate action to a patient for managing epilepsy and other neurological disorders
US20070150025 *28 Dic 200528 Jun 2007Dilorenzo Daniel JMethods and systems for recommending an appropriate pharmacological treatment to a patient for managing epilepsy and other neurological disorders
US20070161919 *29 Dic 200612 Jul 2007Bioneuronics CorporationMethods and systems for continuous EEG monitoring
US20070179558 *30 Ene 20062 Ago 2007Gliner Bradford ESystems and methods for varying electromagnetic and adjunctive neural therapies
US20070208212 *2 May 20076 Sep 2007Dilorenzo Daniel JControlling a Subject's Susceptibility to a Seizure
US20070255323 *28 Abr 20061 Nov 2007Medtronic, Inc.Implantable medical device for the concurrent treatment of a plurality of neurological disorders and method therefore
US20070260107 *5 May 20068 Nov 2007Mishelevich David JTrajectory-based deep-brain stereotactic transcranial magnetic stimulation
US20070287931 *14 Feb 200713 Dic 2007Dilorenzo Daniel JMethods and systems for administering an appropriate pharmacological treatment to a patient for managing epilepsy and other neurological disorders
US20080021341 *21 Jun 200724 Ene 2008Neurovista Corporation A Delware CorporationMethods and Systems for Facilitating Clinical Trials
US20080027348 *21 Jun 200731 Ene 2008Neuro Vista CorporationMinimally Invasive Monitoring Systems for Monitoring a Patient's Propensity for a Neurological Event
US20080103548 *2 Ago 20071 May 2008Northstar Neuroscience, Inc.Methods for treating neurological disorders, including neuropsychiatric and neuropsychological disorders, and associated systems
US20080114417 *14 Nov 200615 May 2008Leyde Kent WSystems and methods of reducing artifact in neurological stimulation systems
US20080140155 *22 Oct 200712 Jun 2008Pilla Arthur AExcessive fibrous capsule formation and capsular contracture apparatus and method for using same
US20080177128 *24 Ene 200824 Jul 2008Neuronetics, Inc.Ferrofluidic cooling and acoustical noise reduction in magnetic stimulators
US20080208074 *21 Feb 200828 Ago 2008David SnyderMethods and Systems for Characterizing and Generating a Patient-Specific Seizure Advisory System
US20080224808 *27 May 200818 Sep 2008Neuronetics, Inc.Ferrofluidic cooling and acoustical noise reduction in magnetic stimulators
US20080269542 *11 Jul 200830 Oct 2008Jacob ZabaraSystems and Methods for Therapeutically Treating Neuro-Psychiatric Disorders and Other Illnesses
US20080306325 *2 Oct 200711 Dic 2008EmkineticsMethod and apparatus for magnetic induction therapy
US20080312706 *21 Mar 200818 Dic 2008The Government Of The United States Of America As Represented By The Secretary Of The Department OfCoil for magnetic stimulation and methods for using the same
US20090099405 *4 Ago 200816 Abr 2009Neostim, Inc.Monophasic multi-coil arrays for trancranial magnetic stimulation
US20090149898 *8 Dic 200811 Jun 2009Northstar Neuroscience, Inc.Systems and Methods for Providing Targeted Neural Stimulation Therapy to Address Neurological Disorders, Including Neuropyschiatric and Neuropyschological Disorders
US20090156884 *26 Nov 200818 Jun 2009Schneider M BretTranscranial magnet stimulation of deep brain targets
US20090171168 *23 Dic 20082 Jul 2009Leyde Kent WSystems and Method for Recording Clinical Manifestations of a Seizure
US20090171420 *23 Dic 20082 Jul 2009David BrownHousing for an Implantable Medical Device
US20090227829 *20 May 200910 Sep 2009Burnett Daniel RMethod and apparatus for magnetic induction therapy
US20090227831 *20 May 200910 Sep 2009Burnett Daniel RMethod and apparatus for magnetic induction therapy
US20090234179 *20 May 200917 Sep 2009Burnett Daniel RMethod and apparatus for magnetic induction therapy
US20090234243 *11 Mar 200917 Sep 2009Schneider M BretRobotic apparatus for targeting and producing deep, focused transcranial magnetic stimulation
US20090240096 *5 Jun 200924 Sep 2009Neuronetics, Inc.Magnetic core for medical procedures
US20090247808 *5 Jun 20091 Oct 2009Neuronetics, Inc.Magnetic core for medical procedures
US20100023089 *30 Sep 200928 Ene 2010Dilorenzo Daniel JohnControlling a Subject's Susceptibility to a Seizure
US20100036453 *11 Feb 2010Northstar Neuroscience, Inc.Techniques for selecting signal delivery sites and other parameters for treating depression and other neurological disorders, and associated systems and methods
US20100057159 *4 Mar 2010Lozano Andres MMethods for targeting deep brain sites to treat mood and/or anxiety disorders
US20100113959 *7 Mar 20076 May 2010Beth Israel Deaconess Medical Center, Inc.Transcranial magnetic stimulation (tms) methods and apparatus
US20100114193 *12 Ene 20106 May 2010Advanced Neuromodulation Systems, Inc.Method of treating depression, mood disorders and anxiety disorders using neuromodulation
US20100125219 *21 Ene 201020 May 2010Harris John FMinimally invasive system for selecting patient-specific therapy parameters
US20100152522 *11 Dic 200817 Jun 2010Yiftach RothSystems and methods for controlling electric field pulse parameters using transcranial magnetic stimulation
US20100160712 *24 Jul 200924 Jun 2010Daniel Rogers BurnettMethod and apparatus for magnetic induction therapy
US20100168501 *23 Jul 20091 Jul 2010Daniel Rogers BurnettMethod and apparatus for magnetic induction therapy
US20100168603 *23 Dic 20091 Jul 2010Himes David MBrain state analysis based on select seizure onset characteristics and clinical manifestations
US20100179627 *11 Ene 201015 Jul 2010Jared FloydMedical Lead Termination Sleeve for Implantable Medical Devices
US20100185042 *5 Feb 201022 Jul 2010Schneider M BretControl and coordination of transcranial magnetic stimulation electromagnets for modulation of deep brain targets
US20100204538 *12 Ago 2010Daniel Rogers BurnettMethod and apparatus for magnetic induction therapy
US20100210893 *19 Ago 2010Pilla Arthur AApparatus and method for electromagnetic treatment of plant, animal, and human tissue, organs, cells, and molecules
US20100210894 *1 Dic 200719 Ago 2010Beth Israel Deaconess Medical Center, Inc.Transcranial magnetic stimulation (TMS) methods and apparatus
US20100217348 *5 May 201026 Ago 2010Neurovista CorporationSystems for Monitoring a Patient's Neurological Disease State
US20100217355 *28 Oct 200826 Ago 2010Peter TassApparatus for the stimulation of neural networks
US20100222631 *30 Abr 20102 Sep 2010Pilla Arthur AApparatus and method for electromagnetic treatment of plant, animal, and human tissue, organs, cells, and molecules
US20100228075 *9 Sep 2010NeuralieveMethod and Apparatus to Record and Analyze TMS Treatments and Results
US20100256436 *30 Jul 20087 Oct 2010Partsch Michael JDevice and method for treating hypertension via non-invasive neuromodulation
US20100256438 *20 Ago 20087 Oct 2010Mishelevich David JFiring patterns for deep brain transcranial magnetic stimulation
US20100256439 *12 Ago 20087 Oct 2010Schneider M BretGantry and switches for position-based triggering of tms pulses in moving coils
US20100286468 *27 Oct 200811 Nov 2010David J MishelevichTranscranial magnetic stimulation with protection of magnet-adjacent structures
US20100286470 *16 Jul 201011 Nov 2010Schneider M BretTranscranial magnetic stimulation field shaping
US20100298623 *24 Oct 200825 Nov 2010Mishelevich David JIntra-session control of transcranial magnetic stimulation
US20100331602 *9 Sep 200830 Dic 2010Mishelevich David JFocused magnetic fields
US20110004270 *6 Ene 2011Sheffield W DouglasMethods and apparatus for effectuating a lasting change in a neural-function of a patient
US20110004450 *9 Oct 20086 Ene 2011Mishelevich David JDisplay of modeled magnetic fields
US20110015464 *20 Ene 2011Neuronetics, Inc.Magnetic core for medical procedures
US20110021863 *27 Ene 2011Daniel Rogers BurnettCooling systems and methods for conductive coils
US20110098779 *26 Oct 201028 Abr 2011Schneider M BretSub-motor-threshold stimulation of deep brain targets using transcranial magnetic stimulation
US20110112352 *12 May 2011Pilla Arthur AApparatus and method for electromagnetic treatment
US20110166430 *7 Jul 2011Harris John FSystem and methods for analyzing seizure activity
US20110172554 *14 Jul 2011Leyde Kent WPatient Entry Recording in an Epilepsy Monitoring System
US20110207989 *25 Ago 2011Pilla Arthur ADevices and method for treatment of degenerative joint diseases with electromagnetic fields
US20110208264 *25 Ago 2011Bradford Evan GlinerSystems and methods for automatically optimizing stimulus parameters and electrode configurations for neuro-stimulators
US20110218820 *8 Sep 2011Himes David MDisplaying and Manipulating Brain Function Data Including Filtering of Annotations
US20110219325 *8 Sep 2011Himes David MDisplaying and Manipulating Brain Function Data Including Enhanced Data Scrolling Functionality
US20110301402 *18 Feb 20098 Dic 2011Meizhou Cornley Hi-Tech Co., Ltd.Ultra-low frequency magnetic stimulating device and operational method thereof
US20130338424 *18 Ene 201319 Dic 2013Children's Medical Center CorporationTranscranial magnetic stimulation (tms) methods and apparatus
US20140316188 *30 Jun 201423 Oct 2014The Trustees Of Columbia University In The City Of New YorkMethods, apparatus, and systems for magnetic stimulation
US20150123608 *9 Ene 20157 May 2015Alfred E. Mann Foundation For Scientific ResearchMicroprocessor controlled class e driver
CN104203342A *21 Mar 201310 Dic 2014波格丹·康斯坦丁·维拉迪拉Apparatus for local application of an extremely low frequency magnetic field to cells
EP1703940A1 *28 Dic 200427 Sep 2006Jacob ZabaraSystems and methods for therapeutically treating neuro-psychiatric disorders and other illnesses
EP1708787A2 *6 Ene 200511 Oct 2006Neuronetics, Inc.Method and apparatus for coil positioning for tms studies
EP2240239A2 *30 Ene 200920 Oct 2010Great Lakes Biosciences, LLCBrain-related chronic pain disorder treatment method and apparatus
EP2240239A4 *30 Ene 200927 Nov 2013Great Lakes Biosciences LlcBrain-related chronic pain disorder treatment method and apparatus
EP2544764A2 *11 Mar 201116 Ene 2013Ronald J. WeinstockEmf probe configurations for electro-modulation of ionic channels of cells and methods of use thereof
EP2547397A2 *18 Mar 201123 Ene 2013Ronald J. WeinstockSystem for diagnosing and treatment of diabetic symptoms
EP2773424A4 *5 Nov 201228 Oct 2015Ivivi Health Sciences LlcMethod and apparatus for electromagnetic treatment of cognition and neurological injury
WO2005105013A2 *26 Abr 200510 Nov 2005Ivivi Technologies, Inc.Electromagnetic treatment induction apparatus and method
WO2005105013A3 *26 Abr 200527 Sep 2007A Dimino AndreElectromagnetic treatment induction apparatus and method
WO2007007058A1 *7 Jul 200618 Ene 2007Isis Innovation LimitedMethod and apparatus for regulating blood pressure
WO2007103475A2 *7 Mar 200713 Sep 2007Beth Israel Deaconess Medical Center, Inc.Transcranial magnetic stimulation (tms) methods and apparatus
WO2007103475A3 *7 Mar 200717 Ene 2008Beth Israel HospitalTranscranial magnetic stimulation (tms) methods and apparatus
WO2008070001A2 *1 Dic 200712 Jun 2008Beth Israel Deaconess Medical Center, Inc.Transcranial magnetic stimulation (tms) methods and apparatus
WO2008070001A3 *1 Dic 20072 Oct 2008Beth Israel HospitalTranscranial magnetic stimulation (tms) methods and apparatus
WO2008145436A1 *31 Mar 20084 Dic 2008Okm Ortungstechni Krauss & Müller GmbhArrangement for supporting, stimulating, and influencing brain activities
WO2009026386A1 *20 Ago 200826 Feb 2009Neostim, Inc.Firing patterns for deep brain transcranial magnetic stimulation
WO2009056106A128 Oct 20087 May 2009Forschungszentrum Jülich GmbHApparatus for the stimulation of neural networks
WO2009143503A2 *26 May 200926 Nov 2009Neostim, Inc.Transcranial magnetic stimulation by enhanced magnetic field perturbations
WO2009143503A3 *26 May 200925 Feb 2010Neostim, Inc.Transcranial magnetic stimulation by enhanced magnetic field perturbations
WO2011098638A1 *9 Feb 201118 Ago 2011Pneuma Research, S.L.Portable digital transducer device that is programmable, has high discrimination at low frequency and low intensity
WO2013067512A1 *5 Nov 201210 May 2013Ivivi Health Sciences, LlcMethod and apparatus for electromagnetic treatment of cognition and neurological injury
WO2013139915A1 *21 Mar 201326 Sep 2013Bogdan Constantin VladilaApparatus for local application of an extremely low frequency magnetic field to cells
WO2014127492A1 *22 Feb 201328 Ago 2014Tianjin Sequence Adjustment Brain Science InstituteReordering therapy instrument
Clasificaciones
Clasificación de EE.UU.600/13, 600/15
Clasificación internacionalA61N2/00, A61N1/36, A61N2/02, A61N1/32, A61N2/04
Clasificación cooperativaA61N1/36021, A61N2/02, A61N1/36082, A61N1/32, A61N1/36025, A61N2/006, A61N1/36071, A61N2/008
Clasificación europeaA61N1/36Z3C, A61N1/36E4, A61N1/36Z, A61N2/00T2, A61N2/02, A61N1/32
Eventos legales
FechaCódigoEventoDescripción
25 May 2006ASAssignment
Owner name: NEUROPACE, INC., CALIFORNIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:FISCHELL, DAVID R.;UPTON, ADRIAN R.M.;REEL/FRAME:017678/0105;SIGNING DATES FROM 20000825 TO 20000830